Idifarma provides contract development and manufacturing services for niche and highly potent generic or innovative drugs

Pharmaceutical R&D and Manufacturing Services

Idifarma is an independent, privately-owned pharmaceutical CDMO based in Spain and specializing in highly potent drugs.

With an experienced staff of 130+ people and over 100 international clients, Idifarma provides a full range of services covering most of the lifecycle of any pharmaceutical product from first pre-formulation trials to commercial manufacturing: drug formulation, development and validation of analytical methods, quality control and batch release in the EU, stability studies, regulatory affairs, GMP contract manufacturing and packaging for clinical or commercial use.

Its state-of-the-art facility features a purpose-built high containment plant for GMP manufacturing of oral solid dosage forms, for both highly potent and non-potent drugs.

Idifarma’s expertise, capabilities and proven track record make it the perfect partner for the development of your projects.

NEWS

LAST TWEETS

¿Quieres formar parte de @Idifarma? Tenemos dos nuevos procesos de selección abiertos (1/4)

Our Business Development Director, Manuel Leal, will be attending #EuroPLX in #London, 25th and 26th February.
If you want to arrange a meeting there, contact us at meet@idifarma.com!
https://t.co/WO4tmtTJgP

#vectorpharma2019 es orgulloso de poder contar con la participación de @Idifarma en su próximo evento en junio 2019 en la Ciudad de México. ¡Si es fabricante o distribuidor de medicamentos y busca crecer internacionalmente, éste es el evento para usted! https://t.co/Dy8B6ssv21

Idifarma wishes you a Merry Christmas and an incredibly Happy New Year!

Our colleague Javier Gurrea has recently published a poster highlighting his work in the improvement of bioavailability of poorly soluble drugs with solid dispersions via Spray Drying technology #spraydryer

Do you want to know more? Click here!
https://t.co/Hrh8xgRgHE

Load More...

Do you want to receive the latest news from Idifarma?

Utilizamos cookies propias y de terceros para realizar el análisis de la navegación de los usuarios y mejorar nuestros servicios. Si continúa navegando, consideramos que acepta su uso. Puede obtener más información, o bien conocer cómo cambiar la configuración pulse aquí ACEPTAR

Aviso de cookies